CROMWELL, Conn.--(BUSINESS WIRE)--Biological Industries USA (BI-USA), a division of Biological Industries Israel LTD, announced today a distribution agreement with Mill Creek Life Sciences LLC, a Rochester, Minnesota start-up that provides tools to support the development and application of cellular and biological therapeutics. The agreement provides for distribution of PLTMax Human Platelet Lysate, a product derived from human platelets and offers unparalleled cell growth and cytogenetic stability of adult stem cells over fetal bovine serum (FBS). PLTMax is available in research and clinical grades and has been used in more than 30 clinical trials worldwide, including several Phase III trials.
We are very pleased to announce our partnership with the team at Mill Creek Life Sciences, said Tanya Potcova, Chief Executive Officer of BI-USA. We have a great opportunity to expand our stem cell portfolio reach here in the US and beyond. We met with Mill Creek at the Cell & Gene Meeting on the Mesa in San Diego last October, where we discussed the potential use of PLTMax with our xeno-free NutriStem MSC Medium and EndoGo XF Medium. We found that we have a mutual interest in serving the needs of the stem cell industry through application development by pairing our leading technology together for use in both research and clinical development. We are excited about the potential for us to expand this collaboration.
Mill Creek Life Sciences is happy to announce this relationship withBiological Industries, said Bill Mirsch, Chief Executive Officer of Mill Creek Life Sciences. We tested their NutriStem MSC Medium and EndoGo XF Medium and found them to be very effective when paired with our PLTMax. We look forward to partnering with BI-USA to provide the best research and GMP grade media options for MSC and endothelial cell therapies.
About Biological Industries
Biological Industries (www.bioind.com) is one of the worlds leading and trusted suppliers to the life sciences industry, with over 35 years experience in cell culture media development and GMP manufacturing. BIs products range from classical cell culture media to supplements and reagents for stem cell research and potential cell therapy applications, to serum-free media and many other products for animal cell culture and molecular biology. BI is committed to a Culture of Excellence through advanced manufacturing and quality-control systems, regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training, and R&D capabilities.
Biological Industries USA (BI-USA) is the US commercialization arm of BI, with facilities in Cromwell, Connecticut. Members of the BI-USA team share a history and expertise of innovation and success in the development of leading-edge technologies in stem cell research, cellular reprogramming, and regenerative medicine.
To receive ongoing BI communications, please join ouremail listor connect with the company onLinkedIn,Twitter, andFacebook.
About Mill Creek Life Sciences
Mill Creek Life Sciences (www.millcreekls.com) is the first company to commercialize human platelet lysate for cellular therapy. A spin-off out of the Human Cell Therapy Laboratory at the Mayo Clinic in Rochester, Minnesota, Mill Creek has been involved in clinical cellular therapies from the beginning. Mill Creek is dedicated to providing the highest quality products for the research and clinical community.
To find out more about Mill Creek Life Sciences, pleaseContact Usor connect with the company onLinkedIn,Twitter, andFacebook.
Read this article:
Biological Industries USA Signs Agreement with Mill Creek Life ... - Business Wire (press release)
- Home | Department of Animal Science - September 25th, 2022
- Blood, sweat, and many miles for cellular therapy - Martha's Vineyard Times - July 27th, 2022
- An Experimental Treatment Failed in Mice, and Researchers Did the Right Thing: They Published About It - UConn Today - UConn - June 22nd, 2022
- BrainStorm Strengthens Executive Team with Key Appointments in R&D and Legal USA - English - USA - English - PR Newswire - May 15th, 2022
- Is Stem Cell Research Illegal in The United States? - April 6th, 2022
- The Pfizer-BioNTech vaccine explained: Whats in it and how does it work - KELOLAND.com - October 16th, 2021
- COVID SCIENCE-Coronavirus may have reached U.S. last December; some cancer therapies may prolong infectiousness - Reuters - December 3rd, 2020
- Yale New Haven Health Docs: Interpreting the Uptick in Covid-19 Cases - Greenwich Free Press - October 31st, 2020
- Stem Cell Therapy Connecticut - Boston Stem Cell Center - October 24th, 2020
- Buzzing to Rebuild Broken Bone: Its Electric! - UConn Today - July 2nd, 2020
- Connecticut governor seeks 3rd party review of nursing homes - Thehour.com - June 13th, 2020
- The Growing Prison Pandemic Wasn't Inevitable, and It's Not Too Late to Fight It - brennancenter.org - April 9th, 2020
- Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular... - April 6th, 2020
- Stem cells that can grow new bone discovered by researchers - Drug Target Review - March 7th, 2020
- University of Connecticut Reverses Prader-Willi Syndrome in Lab by Restoring Silent Genes - Gilmore Health News - January 5th, 2020
- Comparing of Brainstorm Cell Therapeutics Inc. (BCLI) and Cara Therapeutics Inc. (NASDAQ:CARA) - The Broch Herald - December 15th, 2019
- Redding woman donates bone marrow, saves life of a father - FOX61 Hartford - November 19th, 2019
- Center for Regenerative Medicine and Skeletal Development ... - September 14th, 2019
- Connecticut Stem Cells | Stem Cell TV - September 10th, 2019
- Our Doctors - MD Stem Cells - April 6th, 2019
- Hartford, CT - Stem Cells Transplant Institute - January 24th, 2019
- Connecticut Pours Millions Into Embryonic Stem Cell ... - December 21st, 2018
- Stem Cell Transplants - Connecticut Children's Medical Center - November 14th, 2018
- Stem Cell Research Program - Grants - portal.ct.gov - September 24th, 2018
- Stem Cell Research Program - portal.ct.gov - June 23rd, 2018
- Regenerative Therapies | DAVID KLOTH, MD | Connecticut ... - June 23rd, 2018
- FDA Response - U.S. Stem Cell Clinic - October 14th, 2017
- Connecticut & New England Stem Cell Injection Therapy ... - September 24th, 2017
- EBAL schools to raise funds for San Ramon Valley alum Jake Javier - SFGate - August 6th, 2017
- Jeff Jacobs: Hall Of Fame Coach Holowaty Fights Illness And Gives Back - Hartford Courant - July 7th, 2017
- Stormy Chamberlain - Faculty Directory UConn Health - November 27th, 2016
- Faculty Directory UConn Health - November 25th, 2016
- Cells Harvested From Human Urine Used to Make Stem Cells - September 18th, 2016
- Skeletal muscle stem cells - National Center for ... - August 22nd, 2016
- StemCONN - July 31st, 2016
- STEM CELL TECHNOLOGIST with Yale-New Haven Hospital | 31281935 - October 5th, 2015
- Stem cell research blooms at Yale and in Connecticut - October 5th, 2015
- Stem Cells jobs - Science Careers - October 1st, 2015
- Bridgeport Connecticut Stem Cell Research | Bridgeport CT ... - June 20th, 2015
- Stem Cells: Thematic Research Areas - June 4th, 2015
- 365 days: Nature's 10 - December 18th, 2014
- Stem cells - Dr Olivier Clinic - November 16th, 2014
- D.C.s best places to get beautiful: Nusta Spa and Bang Salon - October 16th, 2014
- Connecticut Stem Cell Therapy | Stem Cell Treatments - September 25th, 2014
- Walk To End Alzheimers - September 16th, 2014
- YaleNews | How to tell good stem cells from the bad: Yale ... - September 6th, 2014
- Connecticut (Stem Cell) - what-when-how - September 5th, 2014
- How to tell good stem cells from the bad: Yale researchers answer key question - September 5th, 2014
- Stem Cell Treatment for Spinal Cord Injury (SCI) with CT ... - August 23rd, 2014
- UConn-Wesleyan University Stem Cell Core UConn Health - August 23rd, 2014
- Connecticut Catholics respond to ALS ice bucket controversy - August 23rd, 2014
- Induced Pluripotent Stem Cell Services Induced ... - August 23rd, 2014
- Stem Cell Institute: Cell and Genome Sciences: UConn Health - August 22nd, 2014